- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
452
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
452 companies
ESSA Pharma
Market Cap: US$71.9m
A clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer.
EPIX
US$1.60
7D
-1.2%
1Y
-82.4%
Equillium
Market Cap: US$26.7m
A clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need.
EQ
US$0.77
7D
2.4%
1Y
-70.8%
Lexeo Therapeutics
Market Cap: US$101.5m
Operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases.
LXEO
US$3.11
7D
18.7%
1Y
-80.2%
Sanai Health Industry Group
Market Cap: HK$42.8m
An investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, as well as Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
1889
HK$0.28
7D
-6.7%
1Y
-74.0%
Modus Therapeutics Holding
Market Cap: SEK 43.1m
A biotechnology company, develops a treatment for sepsis and septic shock in Sweden.
MODTX
SEK 1.20
7D
3.0%
1Y
-10.8%
Quantum-Si
Market Cap: US$249.1m
A life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).
QSI
US$1.65
7D
40.4%
1Y
-13.6%
Grace Therapeutics
Market Cap: US$22.1m
Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
GRCE
US$2.29
7D
-4.6%
1Y
-32.6%
Vincerx Pharma
Market Cap: US$1.8m
A clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States.
VINC
US$0.83
7D
-0.1%
1Y
-99.2%
Matinas BioPharma Holdings
Market Cap: US$2.8m
A clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology.
MTNB
US$0.55
7D
0.1%
1Y
-96.0%
Longeveron
Market Cap: US$25.2m
A clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan.
LGVN
US$1.72
7D
17.0%
1Y
-61.0%
Xilio Therapeutics
Market Cap: US$41.4m
A clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies.
XLO
US$0.81
7D
-4.5%
1Y
18.9%
AcouSort
Market Cap: SEK 57.9m
A technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies.
ACOU
SEK 3.88
7D
8.1%
1Y
-61.0%
JW (Cayman) Therapeutics
Market Cap: HK$865.8m
A clinical stage cell therapy company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in the People’s Republic of China.
2126
HK$2.14
7D
7.0%
1Y
2.9%
Fuan Pharmaceutical (Group)
Market Cap: CN¥5.3b
Research and develops, produces, and sells chemical drugs in the People's Republic of China.
300194
CN¥4.49
7D
4.4%
1Y
17.8%
Cynata Therapeutics
Market Cap: AU$48.0m
Engages in the development and commercialization of proprietary induced pluripotent stem cell and mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia.
CYP
AU$0.21
7D
-5.6%
1Y
18.1%
Theracryf
Market Cap: UK£966.7k
A clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioral brain disorders.
TCF
UK£0.0022
7D
0%
1Y
-76.3%
Annovis Bio
Market Cap: US$33.3m
A clinical stage drug platform company, develops drugs to treat neurodegeneration.
ANVS
US$1.93
7D
20.6%
1Y
-79.4%
Zura Bio
Market Cap: US$83.6m
A clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders.
ZURA
US$1.36
7D
14.3%
1Y
-56.5%
Erasca
Market Cap: US$407.1m
A clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.
ERAS
US$1.46
7D
2.1%
1Y
-28.8%
BCAL Diagnostics
Market Cap: AU$35.1m
A screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer.
BDX
AU$0.096
7D
-4.0%
1Y
6.7%
Mereo BioPharma Group
Market Cap: US$405.8m
A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.
MREO
US$2.63
7D
7.3%
1Y
-14.9%
Cardiff Oncology
Market Cap: US$266.1m
A clinical-stage biotechnology company, develops novel therapies to treat various cancers in California.
CRDF
US$4.05
7D
5.5%
1Y
-21.7%
Lipella Pharmaceuticals
Market Cap: US$2.6m
A biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications.
LIPO
US$2.21
7D
1.1%
1Y
-64.1%
Processa Pharmaceuticals
Market Cap: US$2.1m
A clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment.
PCSA
US$0.45
7D
-6.1%
1Y
-80.4%
BiomX
Market Cap: US$10.9m
A clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic disease.
PHGE
US$0.61
7D
3.9%
1Y
-83.1%
Pharming Group
Market Cap: €553.4m
A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.
PHARM
€0.81
7D
9.9%
1Y
-21.0%
Enlivex Therapeutics
Market Cap: US$26.8m
Operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel.
ENLV
US$1.15
7D
-0.9%
1Y
-72.5%
Compass Therapeutics
Market Cap: US$340.2m
A clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States.
CMPX
US$2.35
7D
-0.8%
1Y
4.4%
Immuron
Market Cap: AU$16.6m
A biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada.
IMC
AU$0.071
7D
-11.3%
1Y
-26.0%
Guizhou Xinbang Pharmaceutical
Market Cap: CN¥7.6b
Researches, develops, manufactures, and sells Chinese herbal medicines and other pharmaceutical products in China and internationally.
002390
CN¥3.99
7D
1.0%
1Y
-0.7%
60 Degrees Pharmaceuticals
Market Cap: US$2.8m
A specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States.
SXTP
US$1.95
7D
33.6%
1Y
-87.1%
ALX Oncology Holdings
Market Cap: US$44.3m
A clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States.
ALXO
US$0.78
7D
-12.3%
1Y
-92.8%
AlzeCure Pharma
Market Cap: SEK 263.1m
A pharmaceutical company, develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.
ALZCUR
SEK 2.98
7D
13.7%
1Y
2.1%
bioAffinity Technologies
Market Cap: US$5.7m
Engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung.
BIAF
US$0.29
7D
-19.1%
1Y
-86.3%
Ocumension Therapeutics
Market Cap: HK$4.0b
Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.
1477
HK$4.92
7D
3.6%
1Y
-18.0%
PharmaCyte Biotech
Market Cap: US$11.0m
A biotechnology company, develops and commercializes cellular therapies for cancer in the United States.
PMCB
US$1.58
7D
-11.2%
1Y
-21.4%